Indeed, we found acetylation of tau at a specific residue in the microtubule-binding domain (MTBD) to be exclusively found in tauopathies, providing promise for this epitope as a useful marker of AD and FTLD-tau (Cohen et al., 2011; Irwin et al., 2012a). Here, MAPT is linked to Alzheimer disease.